Pharmaceutical compositions containing pyrimidine derivatives and their applications
TW202631144APending Publication Date: 2026-08-01GUANGDONG RAYNOVENT BIOTECH CO LTD
View PDF 0 Cites 0 Cited by
Patent Information
- Authority / Receiving Office
- TW · TW
- Patent Type
- Applications
- Current Assignee / Owner
- Filing Date
- 2025-12-04
- Publication Date
- 2026-08-01
Smart Images

Figure TWG2TA001071381_001 
Figure TWG2TA001071381_002 
Figure TWG2TA001071381_003
Abstract
This disclosure relates to a pharmaceutical composition containing a pyrimidine derivative and its application. The pharmaceutical composition contains compound 1 as the active ingredient, and further includes a basic reagent and a solubilizer, wherein the molar ratio of the active ingredient to the total amount of the basic reagent and solubilizer is 1:0.80~3.50. The pharmaceutical composition disclosed herein can effectively improve the solubility of compound 1, ensure the stable release of compound 1 in vivo and in vitro, significantly improve the bioavailability of the pharmaceutical formulation, and provide a feasible solution for the clinical use of compound 1.
Need to check novelty before this filing date? Find Prior Art